DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Gilead Sciences (NASDAQ: GILD)

110.54 -2.29 (-2.03%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $110.54 -2.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.63
Previous Close $112.83
Daily Range $108.00 - $112.88
52-Week Range $85.95 - $123.37
Market Cap $162.5B
P/E Ratio 12.85
Dividend (Yield) $1.72 (1.5%)
Ex-Dividend Date
Dividend Pay Date
Volume 14,859,400
Average Daily Volume 10,024,987
Current FY EPS $11.04




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary Rss Feed

3 Stocks for Retirees to Buy

Retirees should be looking for rock-solid businesses that offer good long-term growth prospects and shareholder friendly management teams. Here are 3 company's that fit the bill today.

10 Stocks You Should Be Watching Today

Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday

4 Stocks to Fight the Virus on World Hepatitis Day - Analyst Blog

Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash

Wall Street's Best Think Gilead Will Continue To Outperform The Market

Is Gilead A Buy Pre Earnings?

Stock Market News for July 27, 2015 - Market News

A Big Day For Biotech And It's Not Going So Well

The Importance Of Newly-Released Data For Gilead's HIV Drug Patent Cliff

See More GILD News...

GILD's Top Competitors

GILD $110.54 (-2.03%)
Current stock: GILD
AMGN $165.54 (4.38%)
Current stock: AMGN
CELG $132.56 (-1.73%)
Current stock: CELG
$0.00 (0.00%)
Current stock: